PIVALATE ACHIEVES POSITIVE PHASE 2 DATA IN BRAIN METS TRIAL
![]() |
- F-18 Pivalate PET shows high uptake regardless of origin of primary tumour
- F-18 Pivalate can be used to monitor cerebral metastases
- Patients without previous external beam radiation show higher tumour uptake, while those previously treated show a trend towards lower uptake
MELBOURNE, Australia, Oct. 19, 2022 /PRNewswire/ -- Radiopharm Theranostics...
Read more: PIVALATE ACHIEVES POSITIVE PHASE 2 DATA IN BRAIN METS TRIAL





